Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Global E Online
GLBE
$6.75B
| $5.92M | ﹤0.01% |
+103,788
| New | +$4.3M |
|
2802
Capital City Bank Group
CCBG
$898M
| $5.91M | ﹤0.01% |
229,147
+9,595
| +4% | +$249K |
|
2803
Costamare
CMRE
$1.87B
| $5.9M | ﹤0.01% |
499,894
+24,737
| +5% | +$266K |
|
2804
CuriosityStream
CURI
$150M
| $5.9M | ﹤0.01% |
432,392
+256,597
| +146% | +$3.31M |
|
2805
InfuSystem Holdings
INFU
$186M
| $5.89M | ﹤0.01% |
283,465
+28,575
| +11% | +$578K |
|
2806
Bridgewater Bancshares
BWB
$579M
| $5.88M | ﹤0.01% |
364,403
+4,898
| +1% | +$82K |
|
2807
Lexicon Pharmaceuticals
LXRX
$1.03B
| $5.88M | ﹤0.01% |
1,280,654
+202,496
| +19% | +$975K |
|
2808
Tredegar Corp
TG
$267M
| $5.84M | ﹤0.01% |
424,449
-3,986
| -0.9% | -$60K |
|
2809
Gaotu Techedu
GOTU
$458M
| $5.84M | ﹤0.01% |
399,296
+143,285
| +56% | +$3.19M |
|
2810
Commercial Vehicle Group
CVGI
$156M
| $5.83M | ﹤0.01% |
548,783
+262,880
| +92% | +$2.91M |
|
2811
Civista Bancshares
CIVB
$607M
| $5.83M | ﹤0.01% |
263,809
+14,892
| +6% | +$344K |
|
2812
Ascendis Pharma A/S
ASND
$16B
| $5.82M | ﹤0.01% |
44,277
+814
| +2% | +$108K |
|
2813
Cato Corp
CATO
$69.3M
| $5.81M | ﹤0.01% |
344,210
-2,622
| -0.8% | -$38.8K |
|
2814
Spero Therapeutics
SPRO
$66.6M
| $5.78M | ﹤0.01% |
413,761
+50,150
| +14% | +$701K |
|
|
DSKE
2815
DELISTED
Daseke, Inc. Common Stock
DSKE
| $5.75M | ﹤0.01% |
888,023
-2,113
| -0.2% | -$15.3K |
|
|
AGS
2816
DELISTED
PlayAGS
AGS
| $5.71M | ﹤0.01% |
576,804
+50,131
| +10% | +$462K |
|
2817
Puma Biotechnology
PBYI
$391M
| $5.7M | ﹤0.01% |
621,126
+18,738
| +3% | +$190K |
|
2818
SmartFinancial
SMBK
$909M
| $5.7M | ﹤0.01% |
237,197
+15,400
| +7% | +$362K |
|
|
GSKY
2819
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $5.7M | ﹤0.01% |
1,026,261
+82,822
| +9% | +$496K |
|
2820
UNIFI
UFI
$119M
| $5.69M | ﹤0.01% |
233,603
-1,779
| -0.8% | -$47.5K |
|
2821
Acacia Research
ACTG
$447M
| $5.68M | ﹤0.01% |
840,772
+45,179
| +6% | +$269K |
|
|
ADVM
2822
DELISTED
Adverum Biotechnologies
ADVM
| $5.6M | ﹤0.01% |
160,069
+9,702
| +6% | +$523K |
|
2823
Taysha Gene Therapies
TSHA
$1.66B
| $5.58M | ﹤0.01% |
263,442
+110,980
| +73% | +$2.56M |
|
2824
dLocal
DLO
$4.51B
| $5.56M | ﹤0.01% |
+105,937
| New | +$4.07M |
|
|
DSPG
2825
DELISTED
DSP Group Inc
DSPG
| $5.56M | ﹤0.01% |
375,920
-2,972
| -0.8% | -$44.4K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.